George Rehm

Develops, manufactures and distributes labor monitoring systems

Provides mobile based consumer-centric software platform for the healthcare industry

EMBL Ventures is a hands-on, long-term manager which invests in disruptive biology and life-science related products and technologies with global potential, including therapeutics, target validation and drug design, technology platforms, medical devices and diagnostics developed at the EMBL, from EMBL alumni and from non-EMBL third parties. The firm seeks to invest in entrepreneurial management teams with: a combination of relevant technical expertise, drive, business sense and a down-to-earth attitude; ownership of a proprietary core or platform technology generating a proprietary position or clear competitive advantage in a defined market sector and a solution for a problem with a significant advantage in a market of substantial size and the chance to achieve a leading, sustainable market position. EMBL Ventures typically acts as the lead or co-lead investor for initial financing and also participates in follow-up financing. They partner with their investee companies, taking a seat on the board of directors. To maximize the intrinsic value of a technology or product, the firm's investment strategy targets one of the main value inflection points, typically the transition from early development or conceptual stage up to proof of concept.

Operates as a clinical-stage biopharmaceutical company

Provides health care services

Develops magnetic resonance imaging surface receive coils

Calibrium Private Invt invests in small and middle market companies located in the United States, Austria, Germany and Switzerland. The firm targets companies operating in the fields of healthcare, consumer products, information technology, energy and business services. It provides financing for early and buyout transactions.

Discovers and develops biological markers for the clinical diagnostics marketplace